Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
IL130462D0
Agents and compositions thereof for hair treatment
JPH10182703A
Low molecular fucans and its pharmaceutical composition
EP0765664A1
Stable aqueous suspension of mesalazine for topical use
DE19543750A1
Cathepsin G inhibiting aptamers
EP0695549A1
Use of polydeoxyribonucleotides in diabetic neuropathies
GR940100225A
Composition for the cleaning of the skin, scalp and hair.
CA2100197A1
Use of polysaccharides in acute peripheral neuropathies
IL103757A
Oligodeoxyribonucleotides their preparation and pharmaceutical compositions containing them
EP0530865A1
Composition for the cleaning of skin, scalp and hair
IL102386D0
Compositions for the cleaning of the skin,scalp and hair
US5223609A
Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
US5152998A
Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alpha-cyclodextrin and related intermediate compound
PT98270A
Method for the insulation and purification of monosialoganglioside from a lipidic mixture of complexation with alpha-cyclodextrin and process for the preparation of a related intermediate compound
US5182269A
Composition for topical use having hair stimulating, anti-dandruff and anti-seborrhoic activity
AU5917390A
Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
IL94582D0
Composition for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
EP0340628A2
Sulfoamino derivatives of chondroitin sulfates, of dermaten sulfate and of hyaluronic acid and their pharmacological properties
EP0319890A1
A process for the preparation of monosialoganglioside
EP0317766A1
A method for preventing blood coaguli from being formed in the extra-body circuit of dialysis apparatus and composition useful thereof
